Clinical Trial Update: The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose Vaccination [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports on the safety and immunogenicity of the Varicella vaccine after the second dose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Varicella vaccine (varicella vaccine)

Snippet

Sponsor: Beijing Center for Disease Control and Prevention | Conditions: Varicella | Phase 4 | Status: UNKNOWN